Aspirin is tracked by UniPharma because changes in supply, manufacturing, regulation, or demand can affect sourcing and market decisions for pharma teams operating across Europe and the UK.
Related insights
Latest articles on Aspirin
April 29, 2026
Aspirin Market Growth and Key Developments
The aspirin market is set to reach $3.51B by 2030. Sun Pharma's acquisition of Taro and Bayer's digital health partnership reshape the competitive landscape for buyers and distributors.
Low-Dose Aspirin Shows Promise in Reducing Colorectal Cancer Recurrence in Patients with PI3K Mutations
ALASCCA trial: low-dose aspirin cuts recurrence risk by half in colorectal cancer patients with PI3K mutations. Implications for hospital procurement and genetic testing.